Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel K Hopper

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Seminars in Thoracic and Cardiovascular Surgery|August 5, 2022
Subcutaneous Treprostinil Improves Surgical Candidacy for Next Stage Palliation in Single Ventricle Patients With High-Risk HemodynamicsRachel T Sullivan, Stephanie S Handler, Jeffrey A Feinstein, et al.
The Journal of Pediatrics|May 23, 2018
Treprostinil Improves Persistent Pulmonary Hypertension Associated with Congenital Diaphragmatic HerniaKendall M Lawrence, Holly L Hedrick, Heather M Monk, et al.
The Journal of Pediatrics|November 11, 2019
Inhaled Nitric Oxide Is Associated with Improved Oxygenation in a Subpopulation of Infants with Congenital Diaphragmatic Hernia and Pulmonary HypertensionKendall M Lawrence, Stylianos Monos, Samantha Adams, et al.
Circulation|April 6, 2016
In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target SlugRachel K Hopper, Jan-Renier A J Moonen, Isabel Diebold, et al.
Circulation. Heart Failure|December 9, 2024
Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart AssociationRachel K Hopper, Georg Hansmann, Seth A Hollander, et al.
The Journal of Pediatrics|July 30, 2023
Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial HypertensionCatherine M Avitabile, Delphine Yung, Stephanie Handler, et al.
Journal of Cardiovascular Pharmacology|May 14, 2020
Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial HypertensionRachel K Hopper, D Dunbar Ivy, Delphine Yung, et al.
Pulmonary Circulation|June 20, 2019
Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertensionD Dunbar Ivy, Jeffrey A Feinstein, Delphine Yung, et al.
Journal of Cardiovascular Pharmacology|June 5, 2019
Subcutaneous and Intravenous Treprostinil Pharmacokinetics in Children With Pulmonary Vascular DiseaseKeeley Hall, Michelle Ogawa, Charlotte Sakarovitch, et al.
The Journal of Pediatrics|June 10, 2019
Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network RegistryMei-Sing Ong, Steve Abman, Eric D Austin, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Seminars in Thoracic and Cardiovascular Surgery|August 5, 2022
Subcutaneous Treprostinil Improves Surgical Candidacy for Next Stage Palliation in Single Ventricle Patients With High-Risk HemodynamicsRachel T Sullivan, Stephanie S Handler, Jeffrey A Feinstein, et al.
The Journal of Pediatrics|May 23, 2018
Treprostinil Improves Persistent Pulmonary Hypertension Associated with Congenital Diaphragmatic HerniaKendall M Lawrence, Holly L Hedrick, Heather M Monk, et al.
The Journal of Pediatrics|November 11, 2019
Inhaled Nitric Oxide Is Associated with Improved Oxygenation in a Subpopulation of Infants with Congenital Diaphragmatic Hernia and Pulmonary HypertensionKendall M Lawrence, Stylianos Monos, Samantha Adams, et al.
Circulation|April 6, 2016
In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target SlugRachel K Hopper, Jan-Renier A J Moonen, Isabel Diebold, et al.
Circulation. Heart Failure|December 9, 2024
Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart AssociationRachel K Hopper, Georg Hansmann, Seth A Hollander, et al.
The Journal of Pediatrics|July 30, 2023
Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial HypertensionCatherine M Avitabile, Delphine Yung, Stephanie Handler, et al.
Journal of Cardiovascular Pharmacology|May 14, 2020
Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial HypertensionRachel K Hopper, D Dunbar Ivy, Delphine Yung, et al.
Pulmonary Circulation|June 20, 2019
Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertensionD Dunbar Ivy, Jeffrey A Feinstein, Delphine Yung, et al.
Journal of Cardiovascular Pharmacology|June 5, 2019
Subcutaneous and Intravenous Treprostinil Pharmacokinetics in Children With Pulmonary Vascular DiseaseKeeley Hall, Michelle Ogawa, Charlotte Sakarovitch, et al.
The Journal of Pediatrics|June 10, 2019
Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network RegistryMei-Sing Ong, Steve Abman, Eric D Austin, et al.
Pageof 6